Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jean-Charles Cerottini
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Anatomy
Chemicals & Drugs
Disorders
Physiology
Genes & Molecular Sequences
Living Beings
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
93
Romero, Pedro
58
Valmori, Danila
54
Rimoldi, Donata
41
Guillaume, Philippe
40
Liénard, Danielle
36
Speiser, Daniel
29
Pittet, Mikaël
29
Luescher, Immanuel
25
Dutoit, Valérie
21
Speiser, Daniel
20
Rubio-Godoy, Verena
19
MacDonald, Robson
18
Lejeune, Ferdy
15
Ayyoub, Maha
14
Batard, Pascal
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jean-Charles Cerottini (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bricard Gabriel; Cesson Valerie; Devevre Estelle; Bouzourene Hanifa; Barbey Catherine; Rufer Nathalie; Im Jin S; Alves Pedro M; Martinet Olivier; Halkic Nermin; Cerottini Jean-Charles; Romero Pedro; Porcelli Steven A; Macdonald H Robson; Speiser Daniel E
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(8):5140-51.
-
2007: Alves Pedro M S; Viatte Sebastien; Fagerberg Theres; Michielin Olivier; Bricard Gabriel; Bouzourene Hanifa; Vuilleumier Henri; Kruger Thorsten; Givel Jean-Claude; Lévy Frédéric; Speiser Daniel E; Cerottini Jean-Charles; Romero Pedro
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
Cancer immunology, immunotherapy : CII 2007;56(11):1795-805.
-
2007: Barbey Catherine; Baumgaertner Petra; Devevre Estelle; Rubio-Godoy Verena; Derre Laurent; Bricard Gabriel; Guillaume Philippe; Luescher Immanuel F; Liénard Danielle; Cerottini Jean-Charles; Romero Pedro; Rufer Nathalie; Speiser Daniel E
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(6):3566-74.
-
2007: Appay Victor; Voelter Verena; Rufer Nathalie; Reynard Sévérine; Jandus Camilla; Gasparini Danielle; Lienard Danielle; Speiser Daniel E; Schneider Philippe; Cerottini Jean-Charles; Romero Pedro; Leyvraz Serge
Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(2):240-50.
-
2006: Tabiasco Julie; Devêvre Estelle; Rufer Nathalie; Salaun Bruno; Cerottini Jean-Charles; Speiser Daniel; Romero Pedro
Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(12):8708-13.
-
2006: Bioley Gilles; Jandus Camilla; Tuyaerts Sandra; Rimoldi Donata; Kwok William W; Speiser Daniel E; Tiercy Jean-Marie; Thielemans Kris; Cerottini Jean-Charles; Romero Pedro
Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6769-79.
-
2006: Appay Victor; Jandus Camilla; Voelter Verena; Reynard Severine; Coupland Sarah E; Rimoldi Donata; Lienard Danielle; Guillaume Philippe; Krieg Arthur M; Cerottini Jean-Charles; Romero Pedro; Leyvraz Serge; Rufer Nathalie; Speiser Daniel E
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(3):1670-8.
-
2006: Speiser Daniel E; Baumgaertner Petra; Barbey Catherine; Rubio-Godoy Verena; Moulin Alexandre; Corthesy Patricia; Devevre Estelle; Dietrich Pierre-Yves; Rimoldi Donata; Liénard Danielle; Cerottini Jean-Charles; Romero Pedro; Rufer Nathalie
A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(2):1338-48.
-
2006: Appay Victor; Speiser Daniel E; Rufer Nathalie; Reynard Severine; Barbey Catherine; Cerottini Jean-Charles; Leyvraz Serge; Pinilla Clemencia; Romero Pedro
Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide.
European journal of immunology 2006;36(7):1805-14.
-
2006: Batard Pascal; Peterson Daniel A; Devêvre Estelle; Guillaume Philippe; Cerottini Jean-Charles; Rimoldi Donata; Speiser Daniel E; Winther Lars; Romero Pedro
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.
Journal of immunological methods 2006;310(1-2):136-48.
-
2006: Pittet Mikaël J; Gati Asma; Le Gal Frederic-Anne; Bioley Gilles; Guillaume Philippe; de Smedt Magda; Plum Jean; Speiser Daniel E; Cerottini Jean-Charles; Dietrich Pierre-Yves; Romero Pedro; Zippelius Alfred
Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(4):2330-6.
-
2006: Fagerberg Theres; Cerottini Jean-Charles; Michielin Olivier
Structural prediction of peptides bound to MHC class I.
Journal of molecular biology 2006;356(2):521-46.
-
2006: Chapatte Laurence; Colombetti Sara; Cerottini Jean-Charles; Lévy Frédéric
Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors.
Cancer research 2006;66(2):1155-60.
-
2006: Romero Pedro; Cerottini Jean-Charles; Speiser Daniel E
The human T cell response to melanoma antigens.
Advances in immunology 2006;92():187-224.
-
2005: Romero Pedro; Cerottini Jean-Charles; Luescher Immanuel
On the significance of CD8 alpha alpha expression for T cell memory.
European journal of immunology 2005;35(11):3092-4.
-
2005: Montes M; Rufer N; Appay V; Reynard S; Pittet M J; Speiser D E; Guillaume P; Cerottini J-C; Romero P; Leyvraz S
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy.
Clinical and experimental immunology 2005;142(2):292-302.
-
2005: Le Gal Frédérique-Anne; Ayyoub Maha; Dutoit Valérie; Widmer Valérie; Jäger Elke; Cerottini Jean-Charles; Dietrich Pierre-Yves; Valmori Danila
Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(3):252-7.
-
2005: Ayyoub Maha; Merlo Andrea; Hesdorffer Charles S; Rimoldi Donata; Speiser Daniel; Cerottini Jean-Charles; Chen Yao-Tseng; Old Lloyd J; Stevanovic Stefan; Valmori Danila
CD4+ T cell responses to SSX-4 in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(8):5092-9.
-
2005: Lévy Frédéric; Muehlethaler Katja; Salvi Suzanne; Peitrequin Anne-Lise; Lindholm Cecilia K; Cerottini Jean-Charles; Rimoldi Donata
Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation.
Molecular biology of the cell 2005;16(4):1777-87.
-
2005: Speiser Daniel E; Cerottini Jean-Charles; Romero Pedro
Tumor cell recognition efficiency by T cells.
PLoS medicine 2005;2(3):e77; author reply e95.
-
2005: Speiser Daniel E; Liénard Danielle; Rufer Nathalie; Rubio-Godoy Verena; Rimoldi Donata; Lejeune Ferdy; Krieg Arthur M; Cerottini Jean-Charles; Romero Pedro
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
The Journal of clinical investigation 2005;115(3):739-46.
-
2005: Bricard Gabriel; Bouzourene Hanifa; Martinet Olivier; Rimoldi Donata; Halkic Nermin; Gillet Michel; Chaubert Pascal; Macdonald H Robson; Romero Pedro; Cerottini Jean-Charles; Speiser Daniel E
Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(3):1709-16.
-
2005: Ayyoub Maha; Merlo Andrea; Hesdorffer Charles S; Speiser Daniel; Rimoldi Donata; Cerottini Jean-Charles; Ritter Gerd; Chen Yao-Tseng; Old Lloyd J; Stevanovic Stefan; Valmori Danila
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.
Clinical immunology (Orlando, Fla.) 2005;114(1):70-8.
-
2005: Mahnke Yolanda D; Speiser Daniel; Luescher Immanuel F; Cerottini Jean-Charles; Romero Pedro
Recent advances in tumour antigen-specific therapy: in vivo veritas.
International journal of cancer. Journal international du cancer 2005;113(2):173-8.
-
2005: Michielin Olivier; Blanchet Jean-Sebastien; Fagerberg Theres; Valmori Danila; Rubio-Godoy Verena; Speiser Daniel; Ayyoub Maha; Alves Pedro; Luescher Immanuel; Gairin Jean-Edouard; Cerottini Jean-Charles; Romero Pedro
Tinkering with nature: the tale of optimizing peptide based cancer vaccines.
Cancer treatment and research 2005;123():267-91.
-
2004: Speiser Daniel E; Pittet Mikaël J; Guillaume Philippe; Lubenow Norbert; Hoffman Eric; Cerottini Jean-Charles; Romero Pedro
Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(4):298-308.
-
2004: Ayyoub Maha; Hesdorffer Charles S; Metthez Genevieve; Stevanovic Stefan; Ritter Gerd; Chen Yao-Tseng; Old Lloyd J; Speiser Daniel; Cerottini Jean-Charles; Valmori Danila
Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):7206-11.
-
2004: Liénard Danielle; Rimoldi Donata; Marchand Marie; Dietrich Pierre-Yves; van Baren Nicolas; Geldhof Christine; Batard Pascal; Guillaume Philippe; Ayyoub Maha; Pittet Mikaël J; Zippelius Alfred; Fleischhauer Katharina; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro; Speiser Daniel E
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.
Cancer immunity : a journal of the Academy of Cancer Immunology 2004;4():4.
-
2004: Zippelius Alfred; Batard Pascal; Rubio-Godoy Verena; Bioley Gilles; Liénard Danielle; Lejeune Ferdy; Rimoldi Donata; Guillaume Philippe; Meidenbauer Norbert; Mackensen Andreas; Rufer Nathalie; Lubenow Norbert; Speiser Daniel; Cerottini Jean-Charles; Romero Pedro; Pittet Mikaël J
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.
Cancer research 2004;64(8):2865-73.
-
2004: Ayyoub Maha; Hesdorffer Charles S; Montes Monica; Merlo Andrea; Speiser Daniel; Rimoldi Donata; Cerottini Jean-Charles; Ritter Gerd; Scanlan Matthew; Old Lloyd J; Valmori Danila
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
The Journal of clinical investigation 2004;113(8):1225-33.
-
2004: Zippelius Alfred; Bioley Gilles; Le Gal Frédérique-Anne; Rufer Nathalie; Brandes Marlene; Batard Pascal; De Smedt Magda; Plum Jean; Speiser Daniel E; Cerottini Jean-Charles; Dietrich Pierre-Yves; Romero Pedro; Pittet Mikaël J
Human thymus exports naive CD8 T cells that can home to nonlymphoid tissues.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):2773-7.
-
2004: Romero Pedro; Cerottini Jean-Charles; Speiser Daniel E
Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination.
Cancer immunology, immunotherapy : CII 2004;53(3):249-55.
-
2003: Speiser Daniel E; Pittet Mikaël J; Rimoldi Donata; Guillaume Philippe; Luescher Immanuel F; Liénard Danielle; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.
Seminars in cancer biology 2003;13(6):461-72.
-
2003: Valmori Danila; Dutoit Valérie; Ayyoub Maha; Rimoldi Donata; Guillaume Philippe; Liénard Danielle; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro; Speiser Daniel E
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():15.
-
2003: Rimoldi Donata; Salvi Suzanne; Liénard Danielle; Lejeune Ferdy J; Speiser Daniel; Zografos Leonidas; Cerottini Jean-Charles
Lack of BRAF mutations in uveal melanoma.
Cancer research 2003;63(18):5712-5.
-
2003: Ayyoub Maha; Rimoldi Donata; Guillaume Philippe; Romero Pedro; Cerottini Jean-Charles; Valmori Danila; Speiser Daniel
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Cancer research 2003;63(17):5601-6.
-
2003: Speiser Daniel E; Rimoldi Donata; Batard Pascal; Liénard Danielle; Lejeune Ferdy; Cerottini Jean-Charles; Romero Pedro
Disease-driven T cell activation predicts immune responses to vaccination against melanoma.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():12.
-
2003: Rufer Nathalie; Zippelius Alfred; Batard Pascal; Pittet Mikael J; Kurth Isabel; Corthesy Patricia; Cerottini Jean-Charles; Leyvraz Serge; Roosnek Eddy; Nabholz Markus; Romero Pedro
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.
Blood 2003;102(5):1779-87.
-
2003: Pittet Mikaël J; Rubio-Godoy Verena; Bioley Gilles; Guillaume Philippe; Batard Pascal; Speiser Daniel; Luescher Immanuel; Cerottini Jean-Charles; Romero Pedro; Zippelius Alfred
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(4):1844-9.
-
2003: Dietrich Pierre-Yves; Le Gal Frédérique-Anne; Dutoit Valérie; Pittet Mikäel J; Trautman Lydie; Zippelius Alfred; Cognet Isabelle; Widmer Valérie; Walker Paul R; Michielin Olivier; Guillaume Philippe; Connerotte Thierry; Jotereau Francine; Coulie Pierre G; Romero Pedro; Cerottini Jean-Charles; Bonneville Marc; Valmori Danila
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(10):5103-9.
-
2003: Ayyoub Maha; Zippelius Alfred; Pittet Mikaël J; Rimoldi Donata; Valmori Danila; Cerottini Jean-Charles; Romero Pedro; Lejeune Ferdy; Liénard Danielle; Speiser Daniel E
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):669-77.
-
2003: Guillaume Philippe; Legler Daniel F; Boucheron Nicole; Doucey Marie-Agnès; Cerottini Jean-Charles; Luescher Immanuel F
Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis.
The Journal of biological chemistry 2003;278(7):4500-9.
-
2002: Dutoit Valérie; Taub Robert N; Papadopoulos Kyriakos P; Talbot Susan; Keohan Mary-Louise; Brehm Michelle; Gnjatic Sacha; Harris Paul E; Bisikirska Brygida; Guillaume Philippe; Cerottini Jean-Charles; Hesdorffer Charles S; Old Lloyd J; Valmori Danila
Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.
The Journal of clinical investigation 2002;110(12):1813-22.
-
2002: Romero Pedro; Pittet Mikael; Dutoit Valerie; Zippelius Alfred; Liénard Danielle; Lejeune Ferdy; Guillaume Philippe; Rimoldi Donata; Valmori Danila; Speiser Daniel E; Cerottini Jean-Charles
Therapeutic cancer vaccines based on molecularly defined human tumor antigens.
Vaccine 2002;20 Suppl 4():A2-7.
-
2002: Dutoit Valérie; Guillaume Philippe; Cerottini Jean-Charles; Romero Pedro; Valmori Danila
Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
European journal of immunology 2002;32(11):3285-93.
-
2002: Rubio-Godoy Verena; Dutoit Valérie; Zhao Yingdong; Simon Richard; Guillaume Philippe; Houghten Richard; Romero Pedro; Cerottini Jean-Charles; Pinilla Clemencia; Valmori Danila
Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(10):5696-707.
-
2002: Speiser Daniel E; Cerottini Jean-Charles; Romero Pedro
Can hTERT peptide (540-548) -specific CD8 T cells recognize and kill tumor cells?
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():14.
-
2002: Romero Pedro; Valmori Danila; Pittet Mikael J; Zippelius Alfred; Rimoldi Donata; Lévy Frederic; Dutoit Valérie; Ayyoub Maha; Rubio-Godoy Verena; Michielin Olivier; Guillaume Philippe; Batard Pascal; Luescher Immanuel F; Lejeune Ferdy; Liénard Danielle; Rufer Nathalie; Dietrich Pierre-Yves; Speiser Daniel E; Cerottini Jean-Charles
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.
Immunological reviews 2002;188():81-96.
-
2002: De Mazière Ann M; Muehlethaler Katja; van Donselaar Elly; Salvi Suzanne; Davoust Jean; Cerottini Jean-Charles; Lévy Frédéric; Slot Jan W; Rimoldi Donata
The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins.
Traffic (Copenhagen, Denmark) 2002;3(9):678-93.
-
2002: Rubio-Godoy Verena; Ayyoub Maha; Dutoit Valerie; Servis Catherine; Schink Amy; Rimoldi Donata; Romero Pedro; Cerottini Jean-Charles; Simon Richard; Zhao Yindong; Houghten Richard A; Pinilla Clemencia; Valmori Danila
Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity.
European journal of immunology 2002;32(8):2292-9.
-
2002: Dutoit Valérie; Guillaume Philippe; Romero Pedro; Cerottini Jean-Charles; Valmori Danila
Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():7.
-
2002: Dutoit Valérie; Rubio-Godoy Verena; Pittet Mikäel J; Zippelius Alfred; Dietrich Pierre-Yves; Legal Frédérique Anne; Guillaume Philippe; Romero Pedro; Cerottini Jean-Charles; Houghten Richard A; Pinilla Clemencia; Valmori Danila
Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans.
The Journal of experimental medicine 2002;196(2):207-16.
-
2002: Pittet Mikaël J; Zippelius Alfred; Valmori Danila; Speiser Daniel E; Cerottini Jean-Charles; Romero Pedro
Melan-A/MART-1-specific CD8 T cells: from thymus to tumor.
Trends in immunology 2002;23(7):325-8.
-
2002: Batard Pascal; Szollosi Janos; Luescher Immanuel; Cerottini Jean-Charles; MacDonald Rob; Romero Pedro
Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations.
Cytometry 2002;48(2):97-105.
-
2002: Valmori Danila; Dutoit Valerie; Schnuriger Valerie; Quiquerez Anne-Lise; Pittet Mikaël J; Guillaume Philippe; Rubio-Godoy Verena; Walker Paul R; Rimoldi Donata; Liénard Danielle; Cerottini Jean-Charles; Romero Pedro; Dietrich Pierre-Yves
Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(8):4231-40.
-
2002: Rubio-Godoy Verena; Pinilla Clemencia; Dutoit Valerie; Borras Eva; Simon Richard; Zhao Yingdong; Cerottini Jean-Charles; Romero Pedro; Houghten Richard; Valmori Danila
Toward synthetic combinatorial peptide libraries in positional scanning format (PS-SCL)-based identification of CD8+ Tumor-reactive T-Cell Ligands: a comparative analysis of PS-SCL recognition by a single tumor-reactive CD8+ cytolytic T-lymphocyte clone.
Cancer research 2002;62(7):2058-63.
-
2002: Valmori Danila; Scheibenbogen Carmen; Dutoit Valerie; Nagorsen Dirk; Asemissen Anne Marie; Rubio-Godoy Verena; Rimoldi Donata; Guillaume Philippe; Romero Pedro; Schadendorf Dirk; Lipp Martin; Dietrich Pierre-Yves; Thiel Eckhard; Cerottini Jean-Charles; Liénard Danielle; Keilholz Ulrich
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
Cancer research 2002;62(6):1743-50.
-
2002: Speiser Daniel E; Liénard Danielle; Pittet Mikaël J; Batard Pascal; Rimoldi Donata; Guillaume Philippe; Cerottini Jean-Charles; Romero Pedro
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.
European journal of immunology 2002;32(3):731-41.
-
2002: Zippelius Alfred; Pittet Mikaël J; Batard Pascal; Rufer Nathalie; de Smedt Magda; Guillaume Philippe; Ellefsen Kim; Valmori Danila; Liénard Danielle; Plum Jean; MacDonald H Robson; Speiser Daniel E; Cerottini Jean-Charles; Romero Pedro
Thymic selection generates a large T cell pool recognizing a self-peptide in humans.
The Journal of experimental medicine 2002;195(4):485-94.
-
2002: Ayyoub Maha; Stevanovic Stefan; Sahin Ugur; Guillaume Philippe; Servis Catherine; Rimoldi Donata; Valmori Danila; Romero Pedro; Cerottini Jean-Charles; Rammensee Hans-Georg; Pfreundschuh Michael; Speiser Daniel; Lévy Frédéric
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1717-22.
-
2002: Miconnet Isabelle; Koenig Sylvain; Speiser Daniel; Krieg Arthur; Guillaume Philippe; Cerottini Jean-Charles; Romero Pedro
CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1212-8.
-
2002: Dutoit Valérie; Rubio-Godoy Verena; Doucey Marie-Agnès; Batard Pascal; Liénard Danielle; Rimoldi Donata; Speiser Daniel; Guillaume Philippe; Cerottini Jean-Charles; Romero Pedro; Valmori Danila
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1167-71.
-
2001: Speiser D E; Colonna M; Ayyoub M; Cella M; Pittet M J; Batard P; Valmori D; Guillaume P; Liénard D; Cerottini J C; Romero P
The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(11):6165-70.
-
2001: Rimoldi D; Muehlethaler K; Salvi S; Valmori D; Romero P; Cerottini J C; Levy F
Subcellular localization of the melanoma-associated protein Melan-AMART-1 influences the processing of its HLA-A2-restricted epitope.
The Journal of biological chemistry 2001;276(46):43189-96.
-
2001: Ayyoub M; Migliaccio M; Guillaume P; Liénard D; Cerottini J C; Romero P; Lévy F; Speiser D E; Valmori D
Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing.
European journal of immunology 2001;31(9):2642-51.
-
2001: Rubio-Godoy V; Dutoit V; Rimoldi D; Lienard D; Lejeune F; Speiser D; Guillaume P; Cerottini J C; Romero P; Valmori D
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(18):10302-7.
-
2001: Dutoit V; Rubio-Godoy V; Dietrich P Y; Quiqueres A L; Schnuriger V; Rimoldi D; Liénard D; Speiser D; Guillaume P; Batard P; Cerottini J C; Romero P; Valmori D
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.
Cancer research 2001;61(15):5850-6.
-
2001: Pinilla C; Rubio-Godoy V; Dutoit V; Guillaume P; Simon R; Zhao Y; Houghten R A; Cerottini J C; Romero P; Valmori D
Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes.
Cancer research 2001;61(13):5153-60.
-
2001: Legler D F; Doucey M A; Cerottini J C; Bron C; Luescher I F
Selective inhibition of CTL activation by a dipalmitoyl-phospholipid that prevents the recruitment of signaling molecules to lipid rafts.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(9):1601-3.
-
2001: Pittet M J; Zippelius A; Speiser D E; Assenmacher M; Guillaume P; Valmori D; Liénard D; Lejeune F; Cerottini J C; Romero P
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(12):7634-40.
-
2001: Doucey M A; Legler D F; Boucheron N; Cerottini J C; Bron C; Luescher I F
CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts.
European journal of immunology 2001;31(5):1561-70.
-
2001: Miconnet I; Coste I; Beermann F; Haeuw J F; Cerottini J C; Bonnefoy J Y; Romero P; Renno T
Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(7):4612-9.
-
2001: Robert B; Guillaume P; Luescher I; Doucey M A; Cerottini J C; Romero P; Mach J P
Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments.
Cancer immunity : a journal of the Academy of Cancer Immunology 2001;1():2.
-
2001: Pittet M J; Speiser D E; Liénard D; Valmori D; Guillaume P; Dutoit V; Rimoldi D; Lejeune F; Cerottini J C; Romero P
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):796s-803s.
-
2001: Romero P; Dutoit V; Rubio-Godoy V; Liénard D; Speiser D; Guillaume P; Servis K; Rimoldi D; Cerottini J C; Valmori D
CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequences.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):766s-772s.
-
2001: Dietrich P Y; Walker P R; Quiquerez A L; Perrin G; Dutoit V; Liénard D; Guillaume P; Cerottini J C; Romero P; Valmori D
Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires.
Cancer research 2001;61(5):2047-54.
-
2001: Speiser D E; Migliaccio M; Pittet M J; Valmori D; Liénard D; Lejeune F; Reichenbach P; Guillaume P; Lüscher I; Cerottini J C; Romero P
Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells.
European journal of immunology 2001;31(2):459-66.
-
2001: Valmori D; Dutoit V; Rubio-Godoy V; Chambaz C; Liénard D; Guillaume P; Romero P; Cerottini J C; Rimoldi D
Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma.
Cancer research 2001;61(2):509-12.
-
2000: Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini J C; Lejeune F; Romero P; Valmori D
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(12):7253-61.
-
2000: Jeannin P; Renno T; Goetsch L; Miconnet I; Aubry J P; Delneste Y; Herbault N; Baussant T; Magistrelli G; Soulas C; Romero P; Cerottini J C; Bonnefoy J Y
OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway.
Nature immunology 2000;1(6):502-9.
-
2000: Migliaccio M; Amacker M; Just T; Reichenbach P; Valmori D; Cerottini J C; Romero P; Nabholz M
Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):4978-84.
-
2000: Miconnet I; Servis C; Cerottini J C; Romero P; Lévy F
Amino acid identity and/or position determines the proteasomal cleavage of the HLA-A*0201-restricted peptide tumor antigen MAGE-3271-279.
The Journal of biological chemistry 2000;275(35):26892-7.
-
2000: Valmori D; Dutoit V; Liénard D; Rimoldi D; Pittet M J; Champagne P; Ellefsen K; Sahin U; Speiser D; Lejeune F; Cerottini J C; Romero P
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
Cancer research 2000;60(16):4499-506.
-
2000: Brawand P; Lemonnier F A; MacDonald H R; Cerottini J C; Held W
Transgenic expression of Ly49A on T cells impairs a specific antitumor response.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(4):1871-6.
-
2000: Valmori D; Dutoit V; Liénard D; Lejeune F; Speiser D; Rimoldi D; Cerundolo V; Dietrich P Y; Cerottini J C; Romero P
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(1):533-8.
-
2000: Pittet M J; Speiser D E; Valmori D; Cerottini J C; Romero P
Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(3):1148-52.
-
2000: Valmori D; Lévy F; Miconnet I; Zajac P; Spagnoli G C; Rimoldi D; Liénard D; Cerundolo V; Cerottini J C; Romero P
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):1125-31.
-
1999: Valmori D; Fonteneau J F; Valitutti S; Gervois N; Dunbar R; Liénard D; Rimoldi D; Cerundolo V; Jotereau F; Cerottini J C; Speiser D E; Romero P
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
International immunology 1999;11(12):1971-80.
-
1999: Brawand P; Cerottini J C; MacDonald H R
Hierarchal utilization of different T-cell receptor Vbeta gene segments in the CD8(+)-T-cell response to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Journal of virology 1999;73(11):9161-9.
-
1999: Speiser D E; Pittet M J; Valmori D; Dunbar R; Rimoldi D; Liénard D; MacDonald H R; Cerottini J C; Cerundolo V; Romero P
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
The Journal of experimental medicine 1999;190(6):775-82.
-
1999: Pittet M J; Valmori D; Dunbar P R; Speiser D E; Liénard D; Lejeune F; Fleischhauer K; Cerundolo V; Cerottini J C; Romero P
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
The Journal of experimental medicine 1999;190(5):705-15.
-
1999: Rimoldi D; Salvi S; Reed D; Coulie P; Jongeneel V C; De Plaen E; Brasseur F; Rodriguez A M; Boon T; Cerottini J C
cDNA and protein characterization of human MAGE-10.
International journal of cancer. Journal international du cancer 1999;82(6):901-7.
-
1999: Valmori D; Pittet M J; Vonarbourg C; Rimoldi D; Liénard D; Speiser D; Dunbar R; Cerundolo V; Cerottini J C; Romero P
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
Cancer research 1999;59(16):4050-5.
-
1999: Speiser D E; Valmori D; Rimoldi D; Pittet M J; Liénard D; Cerundolo V; MacDonald H R; Cerottini J C; Romero P
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
European journal of immunology 1999;29(6):1990-9.
-
1999: Valmori D; Pittet M J; Rimoldi D; Liénard D; Dunbar R; Cerundolo V; Lejeune F; Cerottini J C; Romero P
An antigen-targeted approach to adoptive transfer therapy of cancer.
Cancer research 1999;59(9):2167-73.
-
1999: Bour H; Michielin O; Bousso P; Cerottini J C; MacDonald H R
Dramatic influence of V beta gene polymorphism on an antigen-specific CD8+ T cell response in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4647-56.
-
1999: Men Y; Miconnet I; Valmori D; Rimoldi D; Cerottini J C; Romero P
Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3566-73.
-
1999: Valmori D; Gileadi U; Servis C; Dunbar P R; Cerottini J C; Romero P; Cerundolo V; Lévy F
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
The Journal of experimental medicine 1999;189(6):895-906.
-
1999: Kessler B; Michielin O; Blanchard C L; Apostolou I; Delarbre C; Gachelin G; Grégoire C; Malissen B; Cerottini J C; Wurm F; Karplus M; Luescher I F
T cell recognition of hapten. Anatomy of T cell receptor binding of a H-2kd-associated photoreactive peptide derivative.
The Journal of biological chemistry 1999;274(6):3622-31.
-
1998: Valmori D; Gervois N; Rimoldi D; Fonteneau J F; Bonelo A; Liénard D; Rivoltini L; Jotereau F; Cerottini J C; Romero P
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):6956-62.
-
1998: Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini J C; Luescher I F
Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):6939-46.
-
1998: Romero P; Dunbar P R; Valmori D; Pittet M; Ogg G S; Rimoldi D; Chen J L; Liénard D; Cerottini J C; Cerundolo V
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
The Journal of experimental medicine 1998;188(9):1641-50.
-
1998: Hudrisier D; Kessler B; Valitutti S; Horvath C; Cerottini J C; Luescher I F
The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(2):553-62.
-
1998: Bour H; Horvath C; Lurquin C; Cerottini J C; MacDonald H R
Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(11):5522-9.
-
1998: Fleischhauer K; Zino E; Arevalo-Herrera M; Herrera S; Valmori D; Cerottini J C; Benazzi E; Bordignon C; Romero P
Differential expression of HLA-A*02 subtypes in Colombian Blacks and Mestizos.
Tissue antigens 1998;51(2):204-9.
-
1998: Valmori D; Fonteneau J F; Lizana C M; Gervois N; Liénard D; Rimoldi D; Jongeneel V; Jotereau F; Cerottini J C; Romero P
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1750-8.
-
1998: Brawand P; Biasi G; Horvath C; Cerottini J C; MacDonald H R
Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1659-65.
-
1998: Cerottini J C; Valmori D; Rimoldi D; Romero P
Human tumor immunotherapy. New opportunities as well as new challenges.
Advances in experimental medicine and biology 1998;451():247-50.
-
1997: Kessler B; Hudrisier D; Cerottini J C; Luescher I F
Role of CD8 in aberrant function of cytotoxic T lymphocytes.
The Journal of experimental medicine 1997;186(12):2033-8.
-
1997: Reed D S; Romero P; Rimoldi D; Cerottini J C; Schaack J; Jongeneel C V
Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen.
International journal of cancer. Journal international du cancer 1997;72(6):1045-55.
-
1997: Romero P; Gervois N; Schneider J; Escobar P; Valmori D; Pannetier C; Steinle A; Wolfel T; Lienard D; Brichard V; van Pel A; Jotereau F; Cerottini J C
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(5):2366-74.
-
1997: Waanders G A; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich P Y; Cerottini J C; Romero P
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):685-96.
-
1997: Anjuère F; Kuznetsov D; Romero P; Cerottini J C; Jongeneel C V; Luescher I F
Differential roles of T cell receptor alpha and beta chains in ligand binding among H-2Kd-restricted cytolytic T lymphocyte clones specific for a photoreactive Plasmodium berghei circumsporozoite peptide derivative.
The Journal of biological chemistry 1997;272(13):8505-14.
-
1997: Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini J C; Romero P
Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Cancer research 1997;57(4):735-41.
-
1997: Kessler B M; Bassanini P; Cerottini J C; Luescher I F
Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
The Journal of experimental medicine 1997;185(4):629-40.
-
1997: Cerottini J C; Tschopp J
New knowledge about T-cell cytotoxicity.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():75-8.
-
1996: Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French L E; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
Science (New York, N.Y.) 1996;274(5291):1363-6.
-
1996: Carrel S; Schreyer M; Spagnoli G; Cerottini J C; Rimoldi D
Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells.
International journal of cancer. Journal international du cancer 1996;67(3):417-22.
-
1996: Luescher I F; Romero P; Kuznetsov D; Rimoldi D; Coulie P; Cerottini J C; Jongeneel C V
HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.
The Journal of biological chemistry 1996;271(21):12463-71.
-
1996: Cerottini J C; Liénard D; Romero P
Recognition of tumor-associated antigens by T-lymphocytes: perspectives for peptide-based vaccines.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):339-42.
-
1995: Romero P; Pannetier C; Herman J; Jongeneel C V; Cerottini J C; Coulie P G
Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1.
The Journal of experimental medicine 1995;182(4):1019-28.
-
1995: Anjuère F; Layer A; Cerottini J C; Servis C; Luescher I F
Synthesis of a radioiodinated photoreactive MAGE-1 peptide derivative and photoaffinity labeling of cell-associated human leukocyte antigen-A1 molecules.
Analytical biochemistry 1995;229(1):61-7.
-
1995: Luescher I F; Anjuère F; Peitsch M C; Jongeneel C V; Cerottini J C; Romero P
Structural analysis of TCR-ligand interactions studied on H-2Kd-restricted cloned CTL specific for a photoreactive peptide derivative.
Immunity 1995;3(1):51-63.
-
1995: Anjuère F; Horvath C; Cerottini J C; Luescher I F
Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
European journal of immunology 1995;25(6):1535-40.
-
1995: MacDonald H R; Bommhardt U; Cerottini J C
Developmentally regulated expression of P-glycoprotein (multidrug resistance) activity in mouse thymocytes.
European journal of immunology 1995;25(5):1457-60.
-
1994: Bommhardt U; Cerottini J C; MacDonald H R
Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function.
European journal of immunology 1994;24(12):2974-81.
-
1994: Blum S; Milesi R; Tratkiewicz J; Olive D; Gallati H; Cerottini J C; von Fliedner V
Rapid induction of cytolytic T cells via CD28 stimulation for cellular immunotherapy.
Therapeutic immunology 1994;1(3):143-52.
-
1994: Romero P; Cerottini J C; Luescher I F
Efficient in vivo induction of CTL by cell-associated covalent H-2Kd-peptide complexes.
Journal of immunological methods 1994;171(1):73-84.
-
1994: Luescher I F; Cerottini J C; Romero P
Photoaffinity labeling of the T cell receptor on cloned cytotoxic T lymphocytes by covalent photoreactive ligand.
The Journal of biological chemistry 1994;269(8):5574-82.
-
1993: MacDonald H R; Casanova J L; Maryanski J L; Cerottini J C
Oligoclonal expansion of major histocompatibility complex class I-restricted cytolytic T lymphocytes during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction.
The Journal of experimental medicine 1993;177(5):1487-92.
-
1993: Romero P; Casanova J L; Cerottini J C; Maryanski J L; Luescher I F
Differential T cell receptor photoaffinity labeling among H-2Kd restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. Labeling of the alpha-chain correlates with J alpha segment usage.
The Journal of experimental medicine 1993;177(5):1247-56.
-
1993: Casanova J L; Martinon F; Gournier H; Barra C; Pannetier C; Regnault A; Kourilsky P; Cerottini J C; Maryanski J L
T cell receptor selection by and recognition of two class I major histocompatibility complex-restricted antigenic peptides that differ at a single position.
The Journal of experimental medicine 1993;177(3):811-20.
-
1992: López J A; Luescher I F; Cerottini J C
Direct binding of peptides to MHC class I molecules on living cells. Analysis at the single cell level.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(12):3827-35.
-
1992: Casanova J L; Cerottini J C; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald H R; Lemonnier F; Malissen B
H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity.
The Journal of experimental medicine 1992;176(2):439-47.
-
1992: Luescher I F; Lóez J A; Malissen B; Cerottini J C
Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(4):1003-11.
-
1992: von Fliedner V; Miescher S; Gérain J; Gallati H; Barras C; Heumann D; Cerottini J C
Production of tumor necrosis factor-alpha by naive or memory T lymphocytes activated via CD28.
Cellular immunology 1992;139(1):198-207.
-
1991: Cerottini J C; Luescher I F
Direct analysis of peptide binding to cell-associated MHC class I molecules.
Immunology letters 1991;30(2):171-5.
-
1991: Maryanski J L; Romero P; Van Pel A; Boon T; Salemme F R; Cerottini J C; Corradin G
The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides.
International immunology 1991;3(10):1035-42.
-
1991: Luescher I F; Romero P; Cerottini J C; Maryanski J L
Specific binding of antigenic peptides to cell-associated MHC class I molecules.
Nature 1991;351(6321):72-4.
-
1990: MacDonald H R; Budd R C; Cerottini J C
Pgp-1 (Ly 24) as a marker of murine memory T lymphocytes.
Current topics in microbiology and immunology 1990;159():97-109.
-
1989: Carrel S; Lamarre D; Isler P; Rapin C; Fleury S; Salvi S; Sekaly R P; Cerottini J C
A positive signal is transduced via surface CD4 molecules.
Research in immunology 1989;140(5-6):545-61.
-
1989: Jongeneel C V; Shakhov A N; Nedospasov S A; Cerottini J C
Molecular control of tissue-specific expression at the mouse TNF locus.
European journal of immunology 1989;19(3):549-52.
-
1989: Cerottini J C; MacDonald H R
The cellular basis of T-cell memory.
Annual review of immunology 1989;7():77-89.
-
1989: Maryanski J L; Abastado J P; Corradin G; Cerottini J C
Structural features of peptides recognized by H-2Kd-restricted T cells.
Cold Spring Harbor symposia on quantitative biology 1989;54 Pt 1():545-50.
-
1988: Maryanski J L; Pala P; Cerottini J C; MacDonald H R
Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen.
European journal of immunology 1988;18(11):1863-6.
-
1988: Isler P; Salvi S; Rapin C; Giuffrè L; Cerottini J C; Carrel S
Antigen-independent activation of T cells mediated by a novel cell surface heterodimer (Tp135-145).
European journal of immunology 1988;18(10):1491-8.
-
1988: Pala P; Bodmer H C; Pemberton R M; Cerottini J C; Maryanski J L; Askonas B A
Competition between unrelated peptides recognized by H-2-Kd restricted T cells.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(7):2289-94.
-
1988: Maryanski J L; Pala P; Cerottini J C; Corradin G
Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA.
The Journal of experimental medicine 1988;167(4):1391-405.
-
1988: Carrel S; Moretta A; Pantaleo G; Tambussi G; Isler P; Perussia B; Cerottini J C
Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti-CD4 monoclonal antibody.
European journal of immunology 1988;18(3):333-9.
-
1988: Jongeneel C V; Nedospasov S A; Plaetinck G; Naquet P; Cerottini J C
Expression of the tumor necrosis factor locus is not necessary for the cytolytic activity of T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(6):1916-22.
-
1988: Harris D T; Kozumbo W J; Testa J E; Cerutti P A; Cerottini J C
Molecular mechanisms involved in T cell activation. III. The role of extracellular calcium in antigen-induced lymphokine production and interleukin 2-induced proliferation of cloned cytotoxic T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(3):921-7.
-
1988: Pala P; Corradin G; Strachan T; Sodoyer R; Jordan B R; Cerottini J C; Maryanski J L
Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(3):871-7.
-
1988: Cerottini J C; Budd R C; MacDonald H R
Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt-2+ cells.
Annals of the New York Academy of Sciences 1988;532():68-75.
-
1987: Carrel S; Isler P; Salvi S; Giuffrè L; Pantaleo G; Mach J P; Cerottini J C
Identification of a novel 45-kDa cell surface molecule involved in activation of the human Jurkat T cell line.
European journal of immunology 1987;17(10):1395-402.
-
1987: Harris D T; Kozumbo W J; Cerutti P A; Cerottini J C
Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes.
Cellular immunology 1987;109(1):104-14.
-
1987: Carrel S; Salvi S; Giuffrè L; Isler P; Cerottini J C
A novel 90-kDa polypeptide (Tp90) possibly involved in an antigen-independent pathway of T cell activation.
European journal of immunology 1987;17(6):835-41.
-
1987: Budd R C; Cerottini J C; Horvath C; Bron C; Pedrazzini T; Howe R C; MacDonald H R
Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(10):3120-9.
-
1987: Kozumbo W J; Harris D T; Gromkowski S; Cerottini J C; Cerutti P A
Molecular mechanisms involved in T cell activation. II. The phosphatidylinositol signal-transducing mechanism mediates antigen-induced lymphokine production but not interleukin 2-induced proliferation in cloned cytotoxic T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(2):606-12.
-
1987: Harris D T; Kozumbo W J; Cerutti P; Cerottini J C
Molecular mechanisms involved in T cell activation. I. Evidence for independent signal-transducing pathways in lymphokine production vs proliferation in cloned cytotoxic T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(2):600-5.
-
1986: Maryanski J L; Pala P; Corradin G; Jordan B R; Cerottini J C
H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.
Nature 1986;324(6097):578-9.
Sign-in to see more
